Show simple item record

dc.contributor.authorRicci, Liviana
dc.contributor.authorMackie, Joanna
dc.contributor.authorDonachie, Gillian E.
dc.contributor.authorChapuis, Ambre Flora
dc.contributor.authorMezerova, Kristyna
dc.contributor.authorLenardon, Megan
dc.contributor.authorBrown, Alistair
dc.contributor.authorDuncan, Sylvia
dc.contributor.authorWalker, Alan
dc.date.accessioned2022-09-27T10:29:01Z
dc.date.available2022-09-27T10:29:01Z
dc.date.issued2022-10
dc.identifier.citationRicci , L , Mackie , J , Donachie , G E , Chapuis , A F , Mezerova , K , Lenardon , M , Brown , A , Duncan , S & Walker , A 2022 , ' Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans ' , FEMS Microbiology Ecology , vol. 98 , no. 10 , fiac095 . https://doi.org/10.1093/femsec/fiac095en
dc.identifier.issn1574-6941
dc.identifier.otherPURE: 218948388
dc.identifier.otherPURE UUID: 9509a477-7c39-4925-b57b-1f935de226da
dc.identifier.otherPubMed: 36007932
dc.identifier.otherORCID: /0000-0002-4903-0978/work/119826022
dc.identifier.otherORCID: /0000-0001-5099-8495/work/119826226
dc.identifier.otherScopus: 85138458064
dc.identifier.urihttps://hdl.handle.net/2164/19231
dc.descriptionOpen Access via the OUP Agreement Funding: Initial studies were funded from a Wellcome Institutional Strategic Support Fund (ISSF) Seed Corn Award [105625/Z/14/Z]. Thereafter, the research was funded by the Scottish Government’s Rural and Environment Science and Analytical Services (RESAS) division. AJPB was supported by programme grants from the UK Medical Research Council (MR/M026663/1; MR/M026663/2) and by the Medical Research Council Centre for Medical Mycology (MR/N006364/1; MR/N006364/2). Acknowledgements: We thank Dr Donna M. MacCallum for critical reading of the manuscript, the Centre for Genome-Enabled Biology and Medicine at the University of Aberdeen for carrying out the 16S rRNA gene sequencing, and Donna Henderson for GC analysis of bacterial fermentation acids. The authors also acknowledge the support of the Maxwell computer cluster funded by the University of Aberdeen.en
dc.format.extent15
dc.language.isoeng
dc.relation.ispartofFEMS Microbiology Ecologyen
dc.rightsC The Author(s) 2022. Published by Oxford University Press on behalf of FEMS. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectHuman gut microbiotaen
dc.subjectbifidobacteriaen
dc.subjectcolonisation resistanceen
dc.subjectCandida albicansen
dc.subjectshort chain fatty acidsen
dc.subjectlactateen
dc.subjectpHen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject105625/Z/14/Zen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/M026663/1en
dc.subjectMR/M026663/2en
dc.subjectMR/N006364/1en
dc.subjectMR/N006364/2en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleHuman gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicansen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/femsec/fiac095
dc.identifier.vol98en
dc.identifier.iss10en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record